The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection

Journal of Clinical Microbiology

Volumn 54, Issue 3, 2016, Pages 529-534

  Lutgring, Joseph D ^a   Limbago, Brandi M ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; DORIPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM DETECTION; BROTH DILUTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; ENZYME SYNTHESIS; EPSILOMETER TEST; GENE SEQUENCE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REVIEW; DIAGNOSTIC TEST; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DIAGNOSTIC TESTS, ROUTINE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS;

EID: 84959459686     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02771-15     Document Type: Review

References (46)

1. Peleg AY, Hooper DC. 2010. Hospital-acquired infections due to gramnegative bacteria.NEngl J Med 362:1804-1813. http://dx.doi.org/10.1056/NEJMra0904124.
2. Guh AY, Limbago BM, Kallen AJ. 2014. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti Infect Ther 12:565-580. http://dx.doi.org/10.1586/14787210.2014 .902306.
3. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis 53:60-67. http://dx.doi.org/10.1093/cid/cir202.
4. Vasoo S, Barreto JN, Tosh PK. 2015. Emerging issues in gram-negative bacterial resistance: An update for the practicing clinician. Mayo Clin Proc 90:395-403. http://dx.doi.org/10.1016/j.mayocp.2014.12.002.
5. Esterly JS, Wagner J, McLaughlin MM, Postelnick MJ, Qi C, Scheetz MH. 2012. Evaluation of clinical outcomes in patients with bloodstream infections due to gram-negative bacteria according to carbapenem MIC stratification. Antimicrob Agents Chemother 56:4885-4890. http://dx.doi.org/10.1128/AAC.06365-11.
6. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Bush K, Jacoby GA. 2010. Updated functional classification of-lactamases. Antimicrob Agents Chemother 54:969-976. http://dx.doi.org/10.1128/AAC.01009-09.
8. Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, Vagnone PM, Bamberg WM, Janelle SJ, Dumyati G, Concannon C, Beldavs Z, Cunningham M, Cassidy PM, Phipps EC, Kenslow N, Travis T, Lonsway D, Rasheed JK, Limbago BM, Kallen AJ. 2015. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013. JAMA 314:1479-1487. http://dx.doi.org/10.1001/jama.2015.12480.
9. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. 2009. Molecular epidemiology of KPCproducing Klebsiella pneumoniae isolates in the United States: Clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53:3365-3370. http://dx.doi.org/10.1128/AAC.00126-09.
10. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen ø, Seifert H, Woodford N, Nordmann P, European Network on Carbapenemases. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413-431. http://dx.doi.org/10.1111/j.1469-0691.2012.03821.x.
11. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 17:1791-1798. http://dx.doi.org/10.3201/eid1710.110655.
12. Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. 2013. The global spread of healthcare-associated multidrug-resistant bacteria: A perspective from Asia. Clin Infect Dis 56:1310-1318. http://dx.doi.org/10.1093/cid/cit020.
13. Centers for Disease Control and Prevention. 2012. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): 2012 CRE toolkit. Centers for Disease Control and Prevention, Atlanta, GA.
14. Castanheira M, Farrell SE, Krause KM, Jones RN, Sader HS. 2014. Contemporary diversity of beta-lactamases among Enterobacteriaceae in the nine U.S. Census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent beta-lactamase groups. Antimicrob Agents Chemother 58:833-838. http://dx.doi.org/10.1128/AAC .01896-13.
15. Humphries RM, Yang S, Hemarajata P, Ward KW, Hindler JA, Miller SA, Gregson A. 2015. First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 59:6605-6607. http://dx.doi.org/10.1128/AAC.01165-15.
16. Chea N, Bulens SN, Kongphet-Tran T, Lynfield R, Shaw KM, Vagnone PS, Kainer MA, Muleta DB, Wilson L, Vaeth E, Dumyati G, Concannon C, Phipps EC, Culbreath K, Janelle SJ, Bamberg WM, Guh AY, Limbago B, Kallen AJ. 2015. Improved phenotype-based definition for identifying carbapenemase producers among carbapenem-resistant Enterobacteriaceae. Emerg Infect Dis 21:1611-1616. http://dx.doi.org/10.3201/eid2109.150198.
17. Mathers AJ, Carroll J, Sifri CD, Hazen KC. 2013. Modified Hodge test versus indirect carbapenemase test: Prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. J Clin Microbiol 51:1291-1293. http://dx.doi.org/10.1128/JCM.03240-12.
18. Vasoo S, Cunningham SA, Kohner PC, Simner PJ, Mandrekar JN, Lolans K, Hayden MK, Patel R. 2013. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing gram-negative bacilli. J Clin Microbiol 51:3097-3101. http://dx.doi.org/10.1128/JCM .00965-13.
19. Girlich D, Poirel L, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 50:477-479. http://dx.doi.org/10.1128/JCM.05247-11.
20. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45:2723-2725. http://dx.doi.org/10.1128/JCM.00015-07.
21. Carvalhaes CG, Picão RC, Nicoletti AG, Xavier DE, Gales AC. 2010. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: Be aware of false positive results. J Antimicrob Chemother 65:249-251. http://dx.doi.org/10.1093/jac/dkp431.
22. Mochon AB, Garner OB, Hindler JA, Krogstad P, Ward KW, Lewinski MA, Rasheed JK, Anderson KF, Limbago BM, Humphries RM. 2011. New Delhi metallo-lactamase (NDM-1)-producing Klebsiella pneumoniae: Case report and laboratory detection strategies. J Clin Microbiol 49:1667-1670. http://dx.doi.org/10.1128/JCM.00183-11.
23. Nordmann P, Poirel L, Dortet L. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 18:1503-1507. http://dx.doi.org/10.3201/eid1809.120355.
24. Papagiannitsis CC, Študentová V, Izdebski R, Oikonomou O, Pfeifer Y, Petinaki E, Hrabák J. 2015. Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity. J Clin Microbiol 53:1731-1735. http://dx.doi.org/10.1128/JCM.03094-14.
25. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. 2013. Evaluation of the CarbaNPtest for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:4578-4580. http://dx.doi.org/10.1128/AAC.00878-13.
26. Huang TD, Berhin C, Bogaerts P, Glupczynski Y. 2014. Comparative evaluation of two chromogenic tests for rapid detection of carbapenemase in Enterobacteriaceae and in Pseudomonas aeruginosa isolates. J Clin Microbiol 52:3060-3063. http://dx.doi.org/10.1128/JCM.00643-14.
27. Pasteran F, Veliz O, Ceriana P, Lucero C, Rapoport M, Albornoz E, Gomez S, Corso A. 2015. Evaluation of the Blue-Carba test for rapid detection of carbapenemases in gram-negative bacilli. J Clin Microbiol 53:1996-1998. http://dx.doi.org/10.1128/JCM.03026-14.
28. Dortet L, Agathine A, Naas T, Cuzon G, Poirel L, Nordmann P. 2015. Evaluation of the RAPIDEC CARBA NP, the Rapid CARB Screen and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 70:3014-3022. http://dx.doi.org/10.1093/jac/dkv213.
29. Poirel L, Nordmann P. 2015. Rapidec Carba NP test for rapid detection of carbapenemase producers. J Clin Microbiol 53:3003-3008. http://dx.doi.org/10.1128/JCM.00977-15.
30. Tijet N, Patel SN, Melano RG. 15 September 2015. Detection of carbap-enemase activity in Enterobacteriaceae: Comparison of the carbapenem inactivation method versus the Carba NP test. J Antimicrob Chemother http://dx.doi.org/10.1093/jac/dkv283.
31. Van Der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. 2015. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One 10:e0123690. http://dx.doi.org/10.1371/journal.pone.0123690.
32. Hrabák J, Študentová V, Walková R, ?emlic?ková H, Jakubu° V, Chudác?ková E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerová T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50:2441-2443. http://dx.doi.org/10.1128/JCM.01002-12.
33. Girlich D, Halimi D, Zambardi G, Nordmann P. 2013. Evaluation of Etest strips for detection of KPC and metallo-carbapenemases in Enterobacteriaceae. Diagn Microbiol Infect Dis 77:200-201. http://dx.doi.org/10.1016/j.diagmicrobio.2013.08.002.
34. Migliavacca R, Docquier JD, Mugnaioli C, Amicosante G, Daturi R, Lee K, Rossolini GM, Pagani L. 2002. Simple microdilution test for detection of metallo-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol 40:4388-4390. http://dx.doi.org/10.1128/JCM.40.11.4388-4390 .2002.
35. Miriagou V, Tzelepi E, Kotsakis SD, Daikos GL, Casals JB, Tzouvelekis LS. 2013. Combined disc methods for the detection of KPC-and/or VIMpositive Klebsiella pneumoniae: Improving reliability for the double carbapenemase producers. Clin Microbiol Infect 19:E412-E415. http://dx.doi.org/10.1111/1469-0691.12238.
36. Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, Petropoulou D, Sofianou D. 2010. A simple phenotypic method for the differentiation of metallo-beta-lactamases and classAKPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother 65:1664-1671. http://dx.doi.org/10.1093/jac/dkq210.
37. Van Dijk K, Voets GM, Scharringa J, Voskuil S, Fluit AC, Rottier WC, Leverstein-Van Hall MA, Cohen Stuart JW. 2014. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect 20:345-349. http://dx.doi.org/10.1111/1469-0691.12322.
38. Anandan S, Damodaran S, Gopi R, Bakthavatchalam YD, Veeraraghavan B. 2015. Rapid screening for carbapenem resistant organisms: Current results and future approaches. J Clin Diagn Res 9:DM01-DM03. http://dx.doi.org/10.7860/JCDR/2015/14246.6530.
39. Kaase M, Szabados F, Wassill L, Gatermann SG. 2012. Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. J Clin Microbiol 50:3115-3118. http://dx.doi.org/10.1128/JCM.00991-12.
40. Nijhuis R, Samuelsen S, Savelkoul P, Van Zwet A. 2013. Evaluation of a new real-time PCR assay (Check-Direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs. Diagn Microbiol Infect Dis 77:316-320. http://dx.doi.org/10.1016/j.diagmicrobio.2013.09.007.
41. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. 2012. Evaluation of a DNA microarray for the rapid detection of extendedspectrum beta-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR, and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 67:1865-1869. http://dx.doi.org/10.1093/jac/dks156.
42. Dodémont M, De Mendonça R, Nonhoff C, Roisin S, Denis O. 2014. Performance of the Verigene Gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol 52: 3085-3087. http://dx.doi.org/10.1128/JCM.01099-14.
43. Peter H, Berggrav K, Thomas P, Pfeifer Y, Witte W, Templeton K, Bachmann TT. 2012. Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNR microarray test. J Clin Microbiol 50:3990-3998. http://dx.doi.org/10.1128/JCM.00990-12.
44. Tuite N, Reddington K, Barry T, Zumla A, Enne V. 2014. Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gramnegative bacteria: Is it time for a paradigm shift? J Antimicrob Chemother 69:1729-1733. http://dx.doi.org/10.1093/jac/dku083.
45. Mathers AJ, Stoesser N, Sheppard AE, Pankhurst L, Giess A, Yeh AJ, Didelot X, Turner SD, Sebra R, Kasarskis A, Peto T, Crook D, Sifri CD. 2015. Klebsiella pneumoniae carbapenemase (KPC)-producing K. Pneumoniae at a single institution: Insights into endemicity from wholegenome sequencing. Antimicrob Agents Chemother 59:1656-1663. http://dx.doi.org/10.1128/AAC.04292-14.
46. Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NTB, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA. 2015. Vital signs: Estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities-United States. MMWR Morb Mortal Wkly Rep 64:826-831. http://dx.doi.org/10.15585/mmwr.mm6430a4.